drugset / Trial / NCT01027260
Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Patients suffering from Irritable Bowel Syndrome with predominant constipation will be provided with the study medication. The study medication will be evaluated for its efficacy in relieving the symptoms
Timeline
- Start
- 2008-06
- Primary completion
- 2010-08
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Itopride | Small molecule | 50 mg | — |
| Comparator | Itopride | Small molecule | 100 mg | — |